Objectives and method: Survey of subcutaneous drug use and hypodermoclysis with a standardized questionnaire to 27 nursing teams and 52 physicians in a geriatric hospital department (404 beds). Evaluation of license status (CH, F, D and UK) and systematic literature review of 34 drugs used in the geriatric setting. Results: Subcutaneous route is used daily with drugs and fluids mostly for patients in palliative care (83%) or who are dehydrated (54%) when oral or IV administration is impossible (73%, 68% respectively). Morphine (98%), haloperidol (90%), furosemide (69%) and hydromorphone (56%) by bolus (36%) or slow injection over 5 min (82%) are the main drugs used and NaCl 0.9% (95%), and glucose 5%/NaCl 0.9% (31%) are commonly used for rehydration. Among the 34 drugs reviewed, only 13 (38%) are licensed for subcutaneous use in CH, UK, F or D, and only morphine (14 articles of 68) and rehydration (six articles) are evaluated in high level studies. Haloperidol and furosemide are used off-label and there are no well-designed studies supporting their subcutaneous use. Conclusion: There is a lack of information on drugs widely used by subcutaneous route in the elderly. In that context, physicians carry responsibility for the prescription.
Drummond SH , Peterson GM , Galloway JG , Keefe PA . National survey of drug use in palliative care . Palliat Med1996; 10: 119–124 .
2.
Herndon CM , Fike DS . Continuous subcutaneous infusion practices of United States Hospices . J Pain Symptom Manage2001; 22: 1027–1034 .
3.
Negro S , Azuara ML , Sanchez Y , Reyes R , Barcia E . Physical compatibility and in vivo evaluation of drug mixtures for subcutaneous infusion to cancer patients in palliative care . Support Care Cancer2002; 10: 65–70 .
4.
O'Doherty CA , Hall EJ , Schofield L , Zeppetella G . Drugs and syringe drivers: a survey of adult specialist palliative care practice in the United Kingdom and Eire . Palliat Med2001; 15: 149–154 .
5.
Steiner N , Bruera E . Methods of hydration in palliative care patients . J Palliat Care1998; 14: 6–13 .
6.
Frisoli A Jr , de Paula AP , Nasri F . Subcutaneous hydration by hypodermoclysis: a practical approach and low cost treatment for elderly patients . Drugs Aging2000; 16: 313–319 .
7.
Dasgupta M , Binns MA , Rochon PA . Subcutaneous fluid infusion in a long-term care setting . J Am Geriatr Soc2000; 48: 795–799 .
8.
Slesak G , Schnürle JW , Kinzel E , Jakob J , Dietz K . Comparison of subcutaneous and intravenous rehydration in geriatric patients: A randomized trial . JAm Geriatr Soc2003; 51: 155–160 .
9.
Compendium suisse de médicaments 2003. Morant J ed. Bâle: Documed SA , 2003, on-line at http://www.documed.ch, March 2003.
10.
Vidal 2003 Le dictionnaire.79e Ed, Paris: Vidal , 2003, on-line at http://www.vidalpro.net, March 2003.
11.
BNF 45 (British National Formulary) . British Medical Association and Royal Pharmaceutical Society of Great Britain ed. Oxon: Pharmaceutical Press , 2003, on-line at http://www.bnf.org, March 2003.
12.
Rote Liste 2003, Frankfurt: Editio Cantor Verlag , 2003, on-line at http://www.rote-liste.de, March 2003.
13.
Dickman A , Littlewood C , Varga J . The syringe driver: continuous subcutaneous infusions in palliative care. Oxford: Oxford University Press , 2002.
14.
Agence Nationale d'Accréditation et d'Evaluation en Santé (ANAES) . Recommandations pour la pratique clinique: Guide d'analyse de la littérature et gradation des recommandations. Paris, 2000.
15.
Abdulla A , Keast J . Hypodermoclysis as a means of rehydration . Nurs Times1997; 93: 54–55 .
16.
Ansquer C , Marot JP . Nurses and morphine: an assessment of a geriatric protocol . Rev Geriatr2002; 27: 427–432 .
17.
Barberi-Heyob M , Merlin JL , Krakowski I , Kettani C , Collin E , Poulain P . Pharmacocinétique plasmatique de la morphine et de la morphine-6-glucuronide par chromatographie liquide haute performance (HPLC) avec détection coulométrique . Bull Cancer1991; 78: 1063–1070 .
18.
Bricaire F , Castaing JL , Pocidalo JJ , Vilde JL . Etude de la pharmacocinétique et de la tolérance de la ceftriaxone administrée par voie sous-cutanée . Pathol Biol1988; 36: 702–705 .
19.
Bruera E , Macmillan K , Selmser P , MacDonald RN . Decreased local toxicity with subcutaneous diamorphine (heroin): a preliminary report . Pain1990; 43: 91–94 .
20.
Bruera E , Fainsinger R , Spachynski K , Babul N , Harsanyi , Darke AC . Steady-state pharmacokinetic evaluation of a novel, controlled-release morphine suppository and subcutaneous morphine in cancer pain . J Clin Pharmacol1995; 35: 666–672 .
21.
Bruera E , Pereira J , Watanabe S , Belzile M , Kuehn N , Hanson J . Opioid rotation in patients with cancer pain: a retrospective comparison of dose ratios between methadone, hydromorphone, and morphine . Cancer1996; 78: 852–857 .
22.
Cepeda MS , Uribe C , Betancourt J , Rugeles J , Carr DB . Pain relief after knee arthroscopy: intra-articular morphine, intra-articular bupivacaine, or subcutaneous morphine?Reg Anesth1997; 22: 233–238 .
23.
Cools HJM , Berkhout AMM , De Bock GH . Subcutaneous morphine infusion by syringe driver for terminally ill patients . Age Ageing1996; 25: 206–208 .
24.
Cooper IM . Morphine for postoperative analgesia. A comparison of intramuscular and subcutaneous routes of administration . Anaesth Intensive Care1996; 24: 574–578 .
25.
D'Avigneau JM , Tenailleau V . Les médicaments injectables par voie sous-cutanée chez les patients en fin de vie . Rev Geriatr1994; 19: 167–172 .
26.
Dardaine V , Ferry M , Constans T . Subcutaneous infusion or hypodermoclysis: a useful technique in geriatrics . Presse Med1999; 28: 2246–2250 .
27.
Dardaine V , Ferry M , Constans T . L'hypodermoclyse: fiche technique . Rev Med Tours, 1994: 28: 347–349 .
28.
Dardaine V , Garrigue MA , Rapin CH , Constans T . Metabolic and hormonal changes induced by hypodermoclysis of glucose–saline solution in elderly patients . J Gerontol A Biol Sci Med Sci1995; 50A: M334–M36 .
29.
De Conno F , Caraceni A , Zecca E , Spoldi E , Ventafridda V . Continuous subcutaneous infusion of hyoscine butylbromide reduces secretions in patients with gastrointestinal obstruction . J Pain Symptom Manage1991; 6: 484–486 .
30.
Delamaire D , Meigne B , Lecoq A , Cattenoz C , Michel M , Michel O . Un essai contrôlé d'hydratation en faveur d'une actualisation de l'hypodermoclyse chez le sujet âgé . Rev Med Int1992; XIII: S321-S321 .
31.
Doutre MS , Beylot C , Vendeaud-Busquet M , Bioulac-Sage P . Cutaneous necrosis after subcutaneous administration of gentamycin . Therapie1985; 40: 266–267 .
32.
Duterque M , Hubert-Asso AM , Corrard A . Necrotic lesions caused by subcutaneous injections of gentamycin and sisomicin . Ann Dermatol Venereol1985; 112: 707–708 .
33.
Ferry M , Dardaine V , Constans T . Subcutaneous infusion or hypodermoclysis: a practical approach . JAm Geriatr Soc1999; 47: 93–95 .
34.
Ferry M . An alternative to the central venous route in the elderly: rational and practice . Nutr Clin Metab1999; 13: 87–97 .
35.
Gagnon B , Bielech M , Watanabe S , Walker P , Hanson J , Bruera E . The use of intermittent subcutaneous injections of oxycodone for opioid rotation in patients with cancer pain . Support Care Cancer1999; 7: 265–270 .
36.
Gralow I , von Hornstein WF , Schleyer E , Hiddemann W . Pharmacokinetics of buprenorphine in subcutaneous administration . Anasthesiol Intensivmed Notfallmed Schmerzther1995; 30: 412–416 .
37.
Gremaud G , Zulian GB . Indications and limitations of intravenous and subcutaneous midazolam in a palliative care center . J Pain Symptom Manage1998; 15: 331–333 .
38.
Huang ZB , Ahronheim JC . Nutrition and hydration in terminally ill patients: an update . Clin Geriatr Med2000; 16: 313–325 .
39.
Hughes A , Wilcock A , Corcoran R . Ketorolac: continuous subcutaneous infusion for cancer pain . J Pain Symptom Manage1997; 13: 315–316 .
40.
Hunt R , Fazekas B , Thorne D , Brooksbank M . A comparison of subcutaneous morphine and fentanyl in hospice cancer patients . J Pain Symptom Manage1999; 18: 111–119 .
41.
Hussain NA , Warshaw G . Utility of clysis for hydration in nursing home residents . J Am Geriatr Soc1996; 44: 969–973 .
42.
Jaccard S , Aleman MH , Mauran P , Ferry M , Ballereau F . Hypodermoclysis: advantages and practical use . J Pharm Clin1999; 18: 58–59 .
43.
Jayr C , Thomas H , Rey A , Farhat F , Lasser P , Bourgain JL . Post-operative pulmonary complications . Epidural analgesia using bupivacaine and opioids versus parenteral opioidsAnesthesiology. 1993; 78: 666–676 .
44.
Kalso E , Heiskanen T , Rantio M , Rosenberg PH , Vainio A . Epidural and subcutaneous morphine in the management of cancer pain: a double-blind cross-over study . Pain1996; 67: 443–449 .
45.
Keita H , Geachan N , Dahmani S , et al. Comparison between patient-controlled analgesia and subcutaneous morphine in elderly patients after total hip replacement . Br J Anaesth2003; 90: 53–57 .
46.
Klemenz BE . Subcutaneous vs intravenous rehydration therapy in older patients . Dtsch Med Wochenschr1997; 122: 1540–1541 .
47.
Labaille T , Samii K , Mann C , Noviant Y . Post operative respiratory function after subcutaneous and epidural morphine analgesia . Nouv Presse Med1982; 11: 1309–1311 .
48.
Lipschitz S , Campbell AJ , Roberts MA , Wanwimolruk S , McQueen EG , McQueen M , et al. Subcutaneous fluid administration in elderly subjects: validation of an under-used technique . J Am Geriatr Soc1991; 39: 6–9 .
49.
Melin-Coviaux F , Hary L , Hurtel AS , Andrejak M , Grumbach Y . Etude pharmaco-clinique comparative de la ceftriaxone par voie sous-cutanée et intraveineuse chez la personne âgée . Rev Geriatr2000; 25: 337–337 .
50.
Mercadante S , Caligara M , Sapio M , Serretta R , Lodi F . Subcutaneous fentanyl infusion in a patient with bowel obstruction and renal failure . J Pain Symptom Manage1997; 13: 241–244 .
51.
Miller RS , Peterson GM , Abbott F , Maddocks I , Parker D , McLean S . Plasma concentrations of fentanyl with subcutaneous infusion in palliative care patients . Br J Clin Pharmacol1995; 40: 553–556 .
52.
Moriarty D , Hudson E . Hypodermoclysis for rehydration in the community . Br J Community Nurs2001; 6: 437–443 .
53.
Munro AJ , Long GT , Sleigh JW . Nurse-administered subcutaneous morphine is a satisfactory alternative to intravenous patient-controlled analgesia morphine after cardiac surgery . Anesth Analg1998; 87: 11–15 .
54.
Mystakidou K , Kalaidopoulou O , Chondros K , Georgaki S , Papadimitriou L . Comparison of octreotide administration vs conservative treatment in the management of inoperable bowel obstruction in patients with far advanced cancer: a randomized, double-blind, controlled clinical trial . Anticancer Res2002; 22(2B): 1187–1192 .
55.
Nelson KA , Glare PA , Walsh D , Groh ES . A prospective, within-patient, crossover study of continuous intravenous and subcutaneous morphine for chronic cancer pain . J Pain Symptom Manage1997; 13: 262–267 .
56.
Noda J , Umeda S , Aria T , Harima A , Mori K . Continuous subcutaneous infusion of buprenorphine for cancer pain control . Clin J Pain1989; 5: 147–152 .
57.
O'Keeffe ST , Lavan JN . Subcutaneous fluids in elderly hospital patients with cognitive impairment . Gerontology1996; 42: 36–39 .
58.
O'Keeffe S , Geohegan M . Subcutaneous hydration in the elderly . Ir Med J2000; 93: 197–198 .
59.
Paix A , Coleman A , Lees J , Grigson J , Brooksbank M , Thorne D , et al. Subcutaneous fentanyl and sufentanil infusion for morphine intolerance in cancer pain management . Pain1995; 63: 263–269 .
60.
Penso D , Delfraissy JF , Pham Van T , Dormont J . Skin necrosis following administration of subcutaneous gentamicin . Presse Med1984; 13: 1575–1576 .
61.
Picault L , Buronfosse D . Perfusion sous-cutanée ou hypodermoclyse . Rev Geriatr1995; 20: 237–239 .
62.
Plantin P , Mahe M , Le Noac'h E , Le Roy JP . Cutaneous necroses after subcutaneous injections of amikacin . Presse Med1993; 22: 1366-1366 .
63.
Pruvost M , De La Colina OE , Monasterolo NA . Edmonton Injector: Use in Cordoba, Argentina . J Pain Symptom Manage1996; 12: 372–375 .
64.
Rasmussen YH , Thomsen AB . Cutaneous symptoms after continuous subcutaneous injection of morphine . Ugeskr Laeger1996; 158: 3623–3624 .
65.
Rochon PA , Gill SS , Litner J , Fischbach M , Goodison AJ , Gordon M . A systematic review of the evidence for hypodermoclysis to treat dehydration in older people . J Gerontol A Biol Sci Med Sci1997; 52A: M169–M176 .
66.
Ronald AL , Docherty D , Broom J , Chambers WA . Subarachnoid local anesthetic block does not affect morphine absorption from paired intramuscular and subcutaneous injection sites in the elderly patient . Anesth Analg1993; 76: 778–782 .
Schen RJ . Subcutaneous infusions in the elderly . JAm Geriatr Soc1991; 39: 1044–1045 .
69.
Semple TJ , Upton RN , Macintyre PE , Runciman WB , Mather LE . Morphine blood concentrations in elderly postoperative patients following administration via an indwelling subcutaneous cannula . Anaesthesia1997; 52: 318–323 .
70.
Striebel HW , Bonillo B , Schwagmeier R , Dopjans D , Spies C . Self-administered intranasal meperidine for postoperative pain management . Can J Anaesth1995; 42: 287–291 .
71.
Taillandier J , Manigand G , Fixy P , Dumont D . Skin necrosis induced by subcutaneous gentamicin . Presse Med1984; 13: 1574–1575 .
72.
Van Merkestein A . Alternative system for subcutaneous administration of (pain)medication in terminally ill patients . Vox Hosp1996; 20: 10–12 .
73.
Vermeire A , Remon JP , Rosseel MT , Belpaire F , Devulder J , Bogaert MG . Variability of morphine disposition during long-term subcutaneous infusion ill cancer patients . Eur J Clin Pharmacol1998; 53: 325–330 .
74.
Walker P , Watanabe S , Lawlor , Bruera E . Subcutaneous clodronate: a study evaluating efficacy in hypercalcemia of malignancy and local toxicity . Ann Oncol1997; 8: 915–916 .
75.
Watanabe S , Pereira J , Hanson J , Bruera E . Fentanyl by continuous subcutaneous infusion for the management of cancer pain: a retrospective study . J Pain Symptom Manage1998; 16: 323–326 .
76.
White PF . Subcutaneous-PCA: an alternative to IV-PCA for postoperative pain management . Clin J Pain1990; 6: 297–300 .
77.
Worobec G , Brown MK . Hypodermoclysis therapy. In chronic care hospital setting . J Gerontol Nurs1997; 23: 23–28 .
78.
Zeeh J , Poltz S . Exsiccation in geriatric patients: replacement of fluid via subcutaneous infusion . MMW Fortschr Med2000; 142: 40–42 .
79.
Zeeh J , Poltz S , Arras U . Subcutaneous infusion of fluids in geriatric care . Krankenpfl J2000; 38: 16–19 .
80.
Verma AK , da Silva JH , Kuhl DR . Diuretic effects of subcutaneous furosemide in human volunteers: a randomized pilot study . Ann Pharmacother2004; 38: 544–549 .
81.
Grumbach Y , Delahaye F . Antibiothérapie et voie souscutanée en gériatrie . Revue Geriatr2001; 26 (Suppl. A): A53–A56 .
82.
Duncan AR . The use of subcutaneous pamidronate . J Pain Symptom Manage2003; 26: 592–593 .
83.
Zachrisson U , Fürst CJ . Drug infusors in palliative medicine: a Swedish inquiry . J Pain Symptom Manage1998; 15: 299–304 .
84.
Bruera E , Brennais C , Michaud M , et al. Use of the subcutaneous route for the administration of narcotics in patients with cancer pain . Cancer1988; 62: 407–411 .
85.
Bruera E . Ambulatory infusion devices in the continuing care of patients with advanced diseases . J Pain Symptom Manage1990; 5: 287–296 .
86.
Conroy S , Choonara I , Impicciatore P , et al. Survey of unlicensed and off label drug use in paediatric wards in European countries . Br Med J2000; 320: 79–82 .
87.
Atkinson CV , Kirkham SR . Unlicensed uses for medication in a palliative care unit . Palliat Med1999; 13: 145–152 .
88.
Hames A , Wynne HA . Unlicensed and off-label drug use in elderly people . Age Ageing2001; 30: 530–531 .
89.
Use of approved drugs for unlabeled indications . FDA Drug Bull1982; 12: 4–5 .
90.
Art. 3 et 26. Loi fédérale du 15 décembre 2000 sur les médicaments et les dispositifs médicaux (Loi sur les produits thérapeutiques, LPTh) RS 812.21, Confédération helvétique. http://www.admin.ch/ch/f/rs/c812_21.html Last accessed 28 February 2005.
91.
Art. 28. Code civil suisse RS 210. Confédération helvétique. http://www.admin.ch/ch/f/rs/2/210.fr.pdf Last accessed 28 February 2005.
